Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00001971 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Patients With Liver Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 370 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Re-verified, no change to tracked fields
  3. Minor New version filed on ClinicalTrials.gov
  4. Minor 47 versions Re-verified since Jul 11, 2025, no change to tracked fieldsv321-v367
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver. Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked to provide blood and urine samples for laboratory testing and will undergo an ultrasound of the liver. Ultrasound examinations use sound waves to determine the size and texture of the liver. After the initial visit subjects will be requested to follow-up once a year at the outpatient department for a similar check-up. Additional tests may be requested throughout the study to provide information for other research studies and individual consent will be requested. These tests may include liver biopsies, skin biopsies, and / or specialized blood, plasma, and lymphocyte examinations. Subjects that qualify for medications presently being studied may be offered the opportunity to benefit from experimental therapy.
Trial Details
NCT Number NCT00001971
Lead Sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)
Hepatitis D, Hepatitis C, Hepatitis B, Liver Disease
Related terms Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis, Chronic, Liver Diseases
Enrollment 8,050 participants
Start Date
Updated on ClinicalTrials.gov